Vaccine Supply & Logistics

 

 

During the “decade of vaccines” the introduction of new vaccines, the vaccination of groups beyond infancy and tackling the equity gap in providing vaccines to all has meant that outdated immunization supply chains have been overstretched and have outgrown their ability to cope. Join us in Washington to listen and learn from key thought leaders in this space, and showcase your solutions to challenges in vaccine storage, distribution, management and stock control to ensure that we achieve future global immunization goals.

 

DOWNLOAD DRAFT AGENDA

 

2018 AGENDA

 

Vaccine Supply & Logistics, Wednesday 4 April 2018

Vaccine Supply & Logistics
09:00

Chair’s opening remarks

Global Immunization Supply Chains

James Cheyne
Vaccine Supply & Logistics
09:10

Vaccine supply chains in low resource environments: past, present and future perspectives

  • The most fully scrutinized public sector vaccine supply chain are in the least developed countries; 
  • Supply chain strengths and weakness will be demonstrated - there are plenty of both;
  • Implications for the future for vaccine developers and manufactures will highlighted.
Matthew Burt
Vaccine Supply & Logistics
09:40

Success Factors for managing a scalable global clinical supply chain system

  • Managing vaccine supply chains at a global level; setting the right inventory levels, avoiding stock outs, managing supply and demand
  • Challenges associated specifically with vaccine supply;
    • Long lead times
    • Heavy focus on Quality Assurance
    • Complying with global regulation
  • Keeping up with constant improvements in the manufacturing process

Supply Chain System Design

Anup Akkihal
Vaccine Supply & Logistics
10:10

Optimizing supply chains to meet the demands of an increasingly large and costly portfolio of vaccines

10:40

Networking coffee break

Edward Wilson
Vaccine Supply & Logistics
11:40

Driving the immunization supply chain with data

  • Digital solutions and other innovations for improving data visibility, including case study examples
  • How to build a culture of data use
  • Future directions in improving the visibility and use of data
Ms Emily Bancroft
Vaccine Supply & Logistics
12:10

Redesigning immunization supply chains in low and middle-income countries: a case study

  • What is the current scope of the problem
  • What level of change is needed
  • Promising examples of change in sub-Saharan Africa
Vaccine Supply & Logistics
12:40

Industry perspective: Improving your supply chain strategy and system design

1:10

Networking Lunch & Poster Session

Cold Chain, Technology & Data

Paddy Hanlon
Vaccine Supply & Logistics
2:40

Overcoming Key Supply Chain Challenges for Vaccine Shipments

  • Establishing a strong global network increases the strength of your supply chain
  • Explore the latest technological advances in packaging and tracking for complete end to end visibility
  • Learn how performing a detailed risk assessment, including lane verification, helps to ensure a smoother and less risk-sensitive shipment process
Shahrzad Yavari
Vaccine Supply & Logistics
3:10

Innovations in cold chain equipment – preventing freezing in the vaccine cold chain using wireless remote temperature monitoring

  • Many newer, more expensive vaccines are freeze / heat sensitive – so monitoring and maintenance of cold chain equipment is critical.
  • High-income as well as low- and middle-income countries suffer when cold chain equipment fails and tempertatures damage or destroy vaccines.
  • Real-time temperature monitoring allows for quick detection of problems, rapid response to save vaccines, intelligent maintenance, and more.
  • At a high level, the data collected enables evidence-based budgeting, procurement, equipment placement, and effective planning.
Jeffrey Rowland
Vaccine Supply & Logistics
3:40

Engaging private sector innovators to create sustainable change at scale in low resource environments.

  • Bringing business acumen and innovation to bear to save lives and create sustainable health systems
  • What are the biggest supply chain related obstacles to reaching all children with life-saving vaccines
  • How can partnerships be created that provide a win-win for both the public and private sectors
4:10

Networking coffee break

Thomas Sorensen
Vaccine Supply & Logistics
4:40

Rolling out cold chain innovations on a larger scale

  • Experience gained from implementing the greatest revitalization of the cold chain in decades
  • Spreading innovation:
    • What does it take to roll out on a large scale?
    • What are the challenges in reaching so many countries
  • How the roll out is managed between partner organizations

Supply Chain Preparedness

Ms Rebecca Coyle
Vaccine Supply & Logistics
5:10

Discussion: Linking supply chains to immunization registries at home and abroad

  • In the USA:
    • The U.S. Vaccines for Children program move to centralized distribution and the need to automate the ordering process
    • How IIS are used to monitor vaccine usage, project vaccine needs, budget for future needs and monitor storage environments
  • In LMIC:
    • The need to have systems that provide routine program data as well as supply chain data
    • The integration, interoperability & data sharing of these systems with examples in Tanzania and Zambia
    • How has the linkage of systems allowed the tracking of stock levels and projection of accurate usage rates for more efficient ordering and distribution
Geoffrey Glauser
Vaccine Supply & Logistics
5:40

Preparing for a pandemic: successful planning and distribution of large quantities of vaccine within a limited time frame

    style="font-family: calibri light,sans-serif;">
  •              Long term relationships with potential pandemic countermeasure suppliers
  •              Regular planning and response communication with contractual partners and stakeholders.
  •              Advanced development work focusing on potential threats
  •              Vetted and approved response, modeling, capability and capacity plans
6:10

Chair’s closing remarks and close of congress day 2

6:15

Networking Drinks & Party

last published: 22/Feb/18 14:46

Vaccine Supply & Logistics, Thursday 5 April 2018

Vaccine Supply & Logistics
09:00

Chair’s opening remarks

The Future of Supply Chains

Reggie Jackson
Vaccine Supply & Logistics
09:10

The importance of supply chain security – counterfeiting, product theft and vaccine-specific concerns

  • The big picture: why is supply chain security so important?
  • Specific security concerns in vaccine supply for developing countries
    • Alternative distribution infrastructure
    • The ease of obtaining counterfeit vaccines
  • Strategies to prevent counterfeiting 
William Conklin
Vaccine Supply & Logistics
09:40

Supply disruptions – how to limit impact of supply disruptions on country vaccination programs

  • A closer look at the causes of the recent hepatitis vaccine shortage
  • Measures taken to avoid disruptions in supply
  • Potential solutions to avoid disruption from future shortages
    • Should other countries be stock piling?
    • How practical is this?
Julie Jacobson
Vaccine Supply & Logistics
10:10

What can vaccines learn from neglected diseases on effectively engaging the private sector?

  • Introduction to NTDs and shared components with immunization – how are the programs components are similar?
  • Development of global partnership: Uniting to Combat NTDs
    • Relationship with pharma is critical
  • Examples of success stories:
    • supply chain and logistics coordination
10:40

Networking coffee break

12:30

Networking Lunch & Poster Session

AFTERNOON PLENARY OF CONGRESS

Dr Angela Shen
1:40

Report on U.S. vaccine development and innovation including the current landscape, existing challenges, and drivers and levers to incentivize development

  • A combined effort from HHS, NIH, CDC, FDA, BARDA to promote innovation in the development of vaccines that minimize the burden of infectious disease
  • What is the optimal process to determine which vaccines would be beneficial to public health and how information on such vaccines is disseminated to key stakeholders
  • Identifying whether obstacles exist that inhibit the development of beneficial vaccines
  • Recommendations on how best to promote and incentivize vaccine innovation and development
Dr Jeffrey Stoddard
2:10

Zoster vaccine recombinant, adjuvanted: A journey from research to approval

  • Non-live, recombinant vaccine to help prevent herpes zoster (shingles), combining glycoprotein E with an adjuvant system, AS01
  • Sharing positive results from Phase III revaccination study 
Dr Walter A Orenstein
2:40

With polio eradication succeeding, should measles eradication come next?

  • Changing the perception from polio: Focusing on measles elimination to build our overall immunization program
  • Using a “diagonal” approach when dealing with highly contagious preventable diseases like measles
  • Surveillance -  a weakness in our system?
  • Cost of controlling outbreaks and the consequences
Dr Paul Offit
3:10

Vaccine hesitancy: How to respond to the media to advance better health

  • Challenges to communicating science through the opaque prism of the media
  • How certain cultural biases can influence the perception of science 
3:40

3:40 Chair closing remarks and end of congress

last published: 22/Feb/18 14:46

 

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071